AzTrials
AzTrials

Coronary Artery DiseaseNCT04858503

An Internet-based Cardiac Rehabilitation Enhancement (i-CARE) Intervention to Support Self-care of Patients With Coronary Artery Disease

A study testing internet-based cardiac rehabilitation enhancement intervention in people with Coronary Artery Disease, run by The University of Hong Kong at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to examine the effects of an internet-based cardica rehabilitation enhancement (i-CARE) programme for coronary artery disease (CAD) patients on self-care behaviour, biomarkers, physiological, anthropometric parameters, clinical outcomes and self-reported health outcomes and to understand why and how… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Coronary Artery Disease
What is being tested?
internet-based cardiac rehabilitation enhancement intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
268 participants
Where
1 siteHong Kong
Study dates
1 Apr 2022to 31 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ≥18 years of age
  • living in the community,
  • own a smartphone with internet access,
  • communicable in Cantonese,
  • type in Chinese or English,
  • with a confirmed diagnosis of CAD.

Who cannot join

  • enrolled to a structured centre-based or home-based cardiac rehabilitation program, (2) psychiatric problems,
  • impaired cognitive functioning (i.e. Abbreviated Mental Test ≤6), and
  • terminal disease with life expectancy < 1 year.

Trial locations and contacts

1 site in 1 country.

Polly Li, Dr contact

852-39176686

pwcli@hku.hk

Hong Kong1 site, 1 recruiting
  • The School of Nursing

    Hong Kong

    Polly Li, Dr, 852-3917-6686, pwcli@hku.hk

    Recruiting

Other trials in Hong Kong

About this study

Official title: An Internet-based Cardiac Rehabilitation Enhancement (i-CARE) Intervention to Support Self-care of Patients With Coronary Artery Disease: A Mixed-method Study

This study aims to examine the effects of an internet-based cardica rehabilitation enhancement (i-CARE) programme for coronary artery disease (CAD) patients on self-care behaviour, biomarkers, physiological, anthropometric parameters, clinical outcomes and self-reported health outcomes and to understand why and how i-CARE influences patients' health behaviours.

Read the detailed description

This study aims to examine the effects of an internet-based cardica rehabilitation enhancement (i-CARE) programme for coronary artery disease (CAD) patients on self-care behaviour, biomarkers, physiological, anthropometric parameters, clinical outcomes and self-reported health outcomes and to understand why and how i-CARE influences patients' health behaviours.

Cardiovascular disease, a highly prevalent morbidity, is the number one cause of death worldwide and has become a significant public health concern. The majority of these deaths are attributed to an acute manifestation of coronary artery disease (CAD), defined as a narrowing of the coronary arteries that causes insufficient myocardial blood flow. CAD has reached an unequivocal pandemic status globally and locally. CAD imposes not only significant physical and psychosocial burdens on patients, but also enormous service demands on healthcare systems.As a chronic condition, CAD requires patients to practice persistent self-care in a long-term manner for successful disease management. Self-care is considered fundamental to the prevention and management of chronic diseases. Yet, a significant proportion of the CAD population is still engaging in full-time employment, their time availability restricts them to participate in traditional health promotional activities. According to recent systematic reviews, substantial evidence has accumulated to support the positive effects of internet-delivered interventions. Therefore, an internet-based approach with self-care cardiac rehabilitation enhancement may be ab better method of engaging patients in the learning process and arousing their inherent capacities to maintain behavioral modifications. This mixed-method study consists of a two-arm randomized controlled trial and an exploratory qualitative study. For the randomized controlled trial plans to recruit 268 adults from Queen Mary Hospital and Care for Your Heart. Eligible participants will be CAD patients who aged 18 above, living in the community, owning a smartphone with internet access, communicable in Cantonese and able to type in Chinese or English. The participants will be randomly allocated to the intervention or control group to receive i-CARE or usual care, respectively. The study hypotheizes that the CAD patients who receive the i-CARE intervention will report better changes in self-care behaviours, blood pressure, cholesterols, waist-to-height ratio, functional status and HRQoL at 3 and 6 months after the intervention, than those who receive usual care and that the CAD patients who receive the i-CARE intervention will report fewer cardiovascular event rates and mortality at 6 months after the intervention, than those who receive usual care. The findings will advance our knowledge of the empirical effects of internet-based cardiac rehabilitation programme on CAD patients.

Being tested
internet-based cardiac rehabilitation enhancement intervention
Keywords
Self-care, Model of care, Mobile app, Empowerment, Nurse-led, Disease Management, Risk factor control
Medical subject headings
Coronary Artery Disease, Empowerment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • internet-based cardiac rehabilitation enhancement interventionOther

    Participants in the intervention group will receive a 12-week i-CARE intervention, which will be designed to cover the core elements of CAD self-care: self-care maintenance, self-care monitoring and self-care management. The intervention will comprise: 1) a single individualized face-to-face session and 2) an internet-based intervention through a mobile application. Various behaviour change techniques will be used to increase the self-efficacy of CAD patients in enacting self-care behaviours.

Study groups in NCT04858503
Study groupRoleWhat they receive
internet-based cardiac rehabilitation enhancement interventionExperimentalinternet-based cardiac rehabilitation enhancement intervention
Receives: Other: internet-based cardiac rehabilitation enhancement intervention
conventional cares as arranged by hospital or community centersNo interventionParticipants will receive conventional cares as arranged by hospital or community centers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-care behaviour

    the Chinese version of Self-Care of Coronary Heart Disease Inventory (SC-CHDI). This self-reported SC-CHDI (22 items) measures self-care maintenance, self-care management and self-care confidence on a four-point response scale. Each subscale score is transformed to 100 points, with higher scores indicate better self-care for that attribute.

    Measured: Change from Baseline at the 3 months (after the intervention) and 6 months (follow up)

Secondary outcomes (6)
  1. Biomarkers: lipid profile

    POCT

    Measured: Change from Baseline at the 3 months (after the intervention) and 6 months (follow up)

  2. Physiological: blood pressure

    Measure both systolic and diastolic blood pressure

    Measured: Change from Baseline at the 3 months (after the intervention) and 6 months (follow up)

  3. Anthropometric: waist-to-height ratio

    Measure waist-to-height ratio

    Measured: Change from Baseline at the 3 months (after the intervention) and 6 months (follow up)

  4. Clinical: Cardiovascular event rates and mortality

    the admissions, cardiovascular event rates and mortality data will be retrieved

    Measured: Change from Baseline at the 3 months (after the intervention) and 6 months (follow up)

  5. Self-reported health outcomes: functional status

    The functional status will be measured with the Chinese version of Seattle Angina Questionnaire. This 19-item questionnaire consists of five subscales, including physical limitation, angina stability, angina frequency, treatment satisfaction and the disease perception. The respondents have to rate on a 1 to 5 or 6 sequentially coded status. The subscale scores are transformed to a scale of 0 to 100, with higher scores indicate higher level of functioning/ satisfaction and fewer limitations.

    Measured: Change from Baseline at the 3 months (after the intervention) and 6 months (follow up)

  6. Health-related Quality of life (HRQoL)

    The Chinese version of MacNew will be used to measure disease-specific HRQoL.22 It consists of 27 items measuring HRQoL in three domains (physical, emotional and social). Each item is rated on a 1-7 scale, and a global score is calculated by summing the item scores, a higher score represents better HRQoL.

    Measured: Change from Baseline at the 3 months (after the intervention) and 6 months (follow up)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2021
  2. Study start1 Apr 2022
  3. Primary completion30 Jun 2024 (estimated)
  4. Study completion31 Aug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
268 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04858503
Sponsor's protocol ID
NTWC/REC/20139
Status last verified
Nov 2023
First submitted
21 Apr 2021
Last updated
4 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing internet-based cardiac rehabilitation enhancement intervention in people with Coronary Artery Disease, run by The University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Polly Li, Dr (852-39176686, pwcli@hku.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-care behaviour (time frame: Change from Baseline at the 3 months (after the intervention) and 6 months (follow up)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in